KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Sep 25, 2018 $128.67 $130.54 $128.28 $128.99 2 055 737
Sep 24, 2018 $130.03 $130.49 $125.63 $128.51 3 531 200
Sep 21, 2018 $125.09 $125.50 $121.91 $121.99 1 688 980
Sep 20, 2018 $122.69 $124.91 $122.69 $124.61 1 001 090
Sep 19, 2018 $120.79 $123.11 $120.58 $121.97 939 171
Sep 18, 2018 $118.19 $120.94 $117.57 $120.82 1 028 871
Sep 17, 2018 $118.35 $118.65 $117.08 $117.81 927 726
Sep 14, 2018 $119.13 $119.37 $117.28 $118.20 1 321 971
Sep 13, 2018 $118.60 $119.76 $117.35 $119.05 1 444 674
Sep 12, 2018 $117.60 $118.48 $116.29 $118.21 788 481
Sep 11, 2018 $117.60 $118.04 $116.10 $117.52 860 059
Sep 10, 2018 $118.00 $118.52 $117.27 $117.81 860 092
Sep 07, 2018 $116.85 $117.30 $115.40 $117.27 878 143
Sep 06, 2018 $119.92 $121.02 $117.11 $117.41 831 574
Sep 05, 2018 $119.36 $120.61 $118.82 $120.33 1 005 666
Sep 04, 2018 $121.33 $121.78 $118.57 $119.20 1 138 778
Aug 31, 2018 $122.74 $123.74 $121.56 $122.24 975 499
Aug 30, 2018 $122.73 $123.21 $121.78 $122.80 757 986
Aug 29, 2018 $120.48 $123.64 $119.85 $122.81 1 697 987
Aug 28, 2018 $120.32 $122.36 $119.70 $120.30 1 712 222
Aug 27, 2018 $118.28 $121.01 $117.75 $119.97 961 019
Aug 24, 2018 $117.01 $117.95 $116.68 $117.50 622 446
Aug 23, 2018 $117.31 $117.93 $116.27 $116.80 718 817
Aug 22, 2018 $116.52 $118.15 $115.46 $117.70 857 976
Aug 21, 2018 $116.01 $117.25 $115.81 $116.99 1 017 539
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT